HYPD · Hyperion Defi, Inc. · Metrics
Market Cap
$54.23M
Shares
15.54M
HYPD metrics
60 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$3.49
Market cap
$54.23M
Price action
20 metricsPrice change (1W)
+5.8%
Price change (30D)
+28.3%
Price change (3M)
+28.3%
Price change (6M)
-2.2%
Price change (YTD)
-2.0%
Price change (1Y)
-70.9%
Trailing year
Price change (5Y)
—
52-week high
$14.98
52-week low
$2.34
Change from 52-week high
-76.7%
Change from 52-week low
+49.1%
Annualized volatility
117.3%
Annualized volatility (3M)
87.4%
Beta
3.1
RSI (14D)
58.1
Price vs SMA 50
+17.8%
Price vs SMA 200
+2.7%
Avg volume (3M)
510,257
Relative volume
1.0
Average dollar volume
$1.63M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
15.54M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
38.7×
reciprocal yield 2.6%
P / book
0.5
reciprocal yield 188.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
12.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
78.4%
Operating margin
-5,743.5%
Trailing 12 months
Net margin
-5,570.6%
Gross profit (TTM)
$1.10M
Operating profit (TTM)
$4.40M
Net income (TTM)
$6.65M
Trailing 12 months
Diluted EPS (TTM)
$-4.13
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+1,318.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.40M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+384.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
-16.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
6.5%
Return on assets
5.9%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
−$47.61M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
4.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$9.64M
Total assets
$113.14M
Total debt
$7.50M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$13.97M
Capital expenditures (TTM)
$24,583
R&D (TTM)
$908,064
SG&A (TTM)
$15.54M
Stock compensation (TTM)
$3.86M
R&D / revenue
—
Stock compensation / revenue
275.3%
Ownership (13F)
3 metrics13F filers
33
13F filer change QoQ
+4
Institutional ownership
16.2%
Short interest
3 metricsShort interest
8.5%
Latest settlement · 1.6 days to cover
Days to cover
1.6d
Short-squeeze score
54 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—